CURE holdings: all 65 positions
CURE held swaps on IXV worth 239.4% of its net assets on Oct 22, 2026. With the 60.6% it holds directly, its exposure is 300.0%.
Every position
| # | Holding | Weight ↓ |
|---|---|---|
| 1 | IXV swap asset leg | 93.30% |
| 2 | IXV swap asset leg | 62.36% |
| 3 | IXV swap asset leg | 44.24% |
| 4 | IXV swap asset leg | 39.51% |
| 5 | ELI Lilly & Co | 9.65% |
| 6 | Johnson & Johnson | 5.96% |
| 7 | Abbvie Inc | 4.65% |
| 8 | Unitedhealth Group Inc | 3.52% |
| 9 | Merck & Co. Inc. | 3.35% |
| 10 | Thermo Fisher Scientific Inc | 2.31% |
| 11 | Amgen Inc | 2.23% |
| 12 | Gilead Sciences Inc | 1.80% |
| 13 | Abbott Laboratories | 1.64% |
| 14 | Pfizer Inc | 1.60% |
| 15 | Intuitive Surgical Inc | 1.45% |
| 16 | Danaher Corp | 1.33% |
| 17 | Vertex Pharmaceuticals Inc | 1.25% |
| 18 | Bristol-Myers Squibb Co | 1.19% |
| 19 | CVS Health Corp | 1.12% |
| 20 | Medtronic PLC | 1.09% |
| 21 | McKesson Corp | 1.09% |
| 22 | Stryker Corp | 0.99% |
| 23 | Elevance Health Inc | 0.89% |
| 24 | The Cigna Group | 0.77% |
| 25 | Regeneron Pharmaceuticals | 0.74% |
| 26 | Moderna Inc | 0.69% |
| 27 | HCA Healthcare Inc | 0.64% |
| 28 | Boston Scientific Corp | 0.62% |
| 29 | Cencora Inc | 0.60% |
| 30 | Cardinal Health Inc | 0.55% |
| 31 | Becton Dickinson and Co | 0.50% |
| 32 | Edwards Lifesciences Corp | 0.48% |
| 33 | Humana Inc | 0.47% |
| 34 | Agilent Technologies Inc | 0.45% |
| 35 | Veeva Systems Inc-Class A | 0.45% |
| 36 | Iqvia Holdings Inc | 0.42% |
| 37 | Waters Corp | 0.41% |
| 38 | Idexx Laboratories Inc | 0.41% |
| 39 | Illumina Inc | 0.38% |
| 40 | Biogen Inc | 0.35% |
| 41 | Resmed Inc | 0.34% |
| 42 | Centene Corp | 0.33% |
| 43 | Zoetis Inc | 0.31% |
| 44 | Mettler-Toledo International | 0.31% |
| 45 | GE Healthcare Technology | 0.30% |
| 46 | Dexcom Inc | 0.27% |
| 47 | West Pharmaceutical Services | 0.26% |
| 48 | Quest Diagnostics Inc | 0.25% |
| 49 | Labcorp Holdings Inc | 0.25% |
| 50 | Steris PLC | 0.21% |
| 51 | Viatris Inc | 0.20% |
| 52 | Incyte Corp | 0.18% |
| 53 | Zimmer Biomet Holdings Inc | 0.17% |
| 54 | Revvity Inc | 0.16% |
| 55 | Charles River Laboratories | 0.15% |
| 56 | Baxter International Inc | 0.12% |
| 57 | Solventum Corp | 0.12% |
| 58 | Cooper Cos Inc/The | 0.11% |
| 59 | Bio-Techne Corp | 0.10% |
| 60 | Align Technology Inc | 0.10% |
| 61 | Insulet Corp | 0.10% |
| 62 | Universal Health Services-B | 0.09% |
| 63 | Henry Schein Inc | 0.08% |
| 64 | Davita Inc | 0.06% |
| 65 | Hologic Inc- Cvr | 0.00% |
| Dreyfus Govt Cash Man Ins | 19.78% | |
| Goldman Finl Sq Trsry Inst 506 | 8.42% | |
| Goldman Sachs Fin Gov 465 Institut | 8.01% |
Source: Direxion’s daily holdings file. Data as of Oct 22, 2026. Updated each trading day. Report a data error
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. A swap line’s weight is the exposure it gives the fund, not money the fund paid. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. A swap’s Tracks column is the name its line gives what it is written on. Names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of CURE, data as of Oct 22, 2026. https://etfiq.com/funds/cure/holdings/
ETFIQ. (Oct 22, 2026). Holdings of CURE. Retrieved from https://etfiq.com/funds/cure/holdings/
[Holdings of CURE (ETFIQ, Oct 22, 2026)](https://etfiq.com/funds/cure/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.